Description
Book SynopsisOffers a history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. This title details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs.
Trade Review"Based on extensive research, Pills, Power, and Policy is intelligently written, and its points are illustrated with highly readable examples." Health Affairs "Tobbell contributes ... fine historical attention to the development of large pharmaceutical companies ... with a longer story of lobbying and politics." Times Higher Education "Pills, Power, and Policy is an important contribution to our understanding of the science and politics of the pharmaceutical industry." -- Mical Raz, M.D., Ph.D. -- Yale University School of Medicine Inquiry "[A] well-researched and skillfully argued volume." -- Scott H. Podolsky, Harvard Medical School Bulletin Of The History Of Medicine "A compact, highly readable volume that is accessible to multiple audiences." -- Jeremy A. Greene Journal of American History "A thoughtful, well researched, and refreshingly well-written study... Anyone interested in how health policy has been shaped will profit from this most enjoyable book." -- John P. Swann Journal of the History of Medicine "A strong case for the proposition that the history of pharmaceutical regulation in the USA is essential for an understanding of contemporary policy debates in America." -- Wayne Hall Social History of Medicine
Table of ContentsForeword Acknowledgments Introduction: Pharmaceutical Politics, Then and Now Part I: Forging Pharmaceutical Relations 1. Knowledgeable Relations: The Building of a Pharmaceutical Research Network 2. Workforce Relations: The Invention of the Pharmaceutical Postdoctoral Fellowship 3. Professional Relations: Crafting the Public Image of the Health Care Team Part II: Allied against Reform 4. Cold War Alliances: Kefauver's Bid for Pharmaceutical Reform 5. Expert Alliances: The Creation of the Drug Research Board 6. Generic Alliances and the Backlash against Regulatory Reform Epilogue Notes Bibliography Index
